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Abstract Low and disturbed blood flow drives the progression of arterial diseases including
atherosclerosis and aneurysms. The endothelial response to flow and its interactions with recruited
platelets and leukocytes determine disease progression. Here, we report widespread changes in
alternative splicing of pre-mRNA in the flow-activated murine arterial endothelium in vivo.
Alternative splicing was suppressed by depletion of platelets and macrophages recruited to the
arterial endothelium under low and disturbed flow. Binding motifs for the Rbfox-family are enriched
adjacent to many of the regulated exons. Endothelial deletion of Rbfox2, the only family member
expressed in arterial endothelium, suppresses a subset of the changes in transcription and RNA
splicing induced by low flow. Our data reveal an alternative splicing program activated by Rbfox2
in the endothelium on recruitment of platelets and macrophages and demonstrate its relevance in
transcriptional responses during flow-driven vascular inflammation.
DOI: https://doi.org/10.7554/eLife.29494.001
Introduction
Exposure of arterial endothelium to low and disturbed flow initiates a process of endothelial activa-
tion, resulting in increased expression of adhesion molecules and the rolling, adhesion and extrava-
sation of leukocytes (Gimbrone and Garcı´a-Carden˜a, 2013; Ley et al., 2007). The level of shear
stress to which endothelium is exposed is one of the best predictors of atherosclerosis and growth
and rupture of aneurysms (Boussel et al., 2008; Cheng et al., 2006; Cicha et al., 2011;
Xiang et al., 2011). Experiments with isolated endothelial cells exposed to altered flow in vitro
revealed that increased laminar flow alone was sufficient to suppress endothelial apoptosis and
expression of endothelial leukocyte recruitment molecules such as Icam1 (Nagel et al., 1994). Sub-
sequent work revealed transcriptional programs induced by steady flow and suppressed by low and
disturbed flow in vitro and in vivo (Dai et al., 2004). Many of these programs could be recapitulated
by Erk5 activation and increased expression of the transcription factor Klf2 (Dekker et al., 2006;
Lin et al., 2005; Parmar et al., 2006). Interfering with these programs increased markers of endo-
thelial dysfunction and disease progression in atherosclerosis (Dekker et al., 2006; Lin et al., 2005;
Parmar et al., 2006). Thus, exposure of arterial endothelium to low flow initiates a program of endo-
thelial dysfunction characterized by transcriptional changes and alterations in the expression of leu-
kocyte recruitment molecules.
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Most work to date has focused on the primary endothelial response to low flow, rather than the
chronic interactions with immune cells under low flow in vivo. However, chronic inflammation con-
tributes to a wide variety of dangerous cardiovascular lesions, including the erosion and rupture of
atherosclerotic plaques and aneurysms. Not surprisingly, inflammation is a clinical target in athero-
sclerosis (Ridker et al., 2012) and aortic aneurysm (Davis et al., 2014). The adaptive immune
response is also being targeted, with good efficacy in pre-clinical models of atherosclerosis
(Kimura et al., 2015). Historical perspectives on inflammation have typically focused on the leuko-
cytes recruited in large numbers from the blood to the tissues, however, the endothelial lining of
arterial vessels plays a critical role as a regulator of multiple steps in the cascade, including effects
on immune cell recruitment, trafficking into tissues, and local activity (Carman and Martinelli, 2015;
Galkina and Ley, 2009; Pober and Sessa, 2007). The endothelium, as the interface between
recruited immune cells and tissues, and as a local regulator of the inflammatory process, is an attrac-
tive target for the regulation of local inflammation, potentially avoiding complications of systemic
immunosuppressive agents.
Recently, we discovered that, in a chronic in vivo model of low flow, changes in alternative splic-
ing of the extracellular matrix protein fibronectin (FN) prevented hemorrhagic rupture of the intima
(Murphy and Hynes, 2014). Through alternative splicing, a single pre-mRNA produced from a tran-
scribed gene can be spliced in different ways to generate multiple, sometimes hundreds, of various
isoforms (Nilsen and Graveley, 2010; Wang and Burge, 2008). These new isoforms often lend
completely novel interactions to proteins, resulting in interaction profiles often as divergent from the
‘canonical’ isoform as from other unrelated proteins (Yang et al., 2016). Interestingly, the splicing
changes we observed in Fn, resulting in the incorporation of alternative exons EIIIA and EIIIB, could
be blocked by the depletion of macrophages, which are recruited to the arterial endothelium under
low flow (Murphy and Hynes, 2014). Our results suggested that regulation of alternative splicing
might play an important role in the endothelial interaction with recruited immune cells and regula-
tion of chronic arterial inflammation.
Here, we test the possibility that alternative splicing is broadly regulated in the arterial endothe-
lium by low and disturbed flow, and hypothesize that alternative splicing events co-regulated with
alternatively spliced Fn exons EIIIA and EIIIB may be important in coordinating the response of the
arterial endothelium to low flow.
Results
Low flow induces a program of alternative splicing in the arterial intima
To determine the extent of alternative splicing changes in the arterial intima under low-flow condi-
tions, we prepared pools of intimal RNA from the carotid arteries of mice exposed to low flow for
48 hr (Figure 1A). Control pools of RNA were prepared from mice subjected to a sham operation,
or from the contralateral arteries of ligated mice, which were exposed to high flow. We detected
4766 differentially expressed genes between the low-flow carotid and the contralateral high-flow
carotid (Padj <0.05 by DEseq2, N = 3 per group), which overlapped and extended previous experi-
ments in this system and in vitro (Dai et al., 2004; Ni et al., 2010) (Figure 1B). We observed excel-
lent correlation in Log2 fold-change between biological replicates (Pearson correlation of 0.82 for all
genes, and 0.98 for genes found to be significantly regulated by low flow). Low flow, rather than
high flow in the contralateral artery, was responsible for the majority of changes in mRNA levels, rel-
ative to the normal-flow, sham-operated controls (Figure 1—figure supplement 1). The flow-
responsive signature included reduction in expression of the canonical flow-responsive genes Klf2
and Klf4 and we also detected an increase in signal from innate immune cells (CD45, F4/80, CD11b,
Cxcr2; Figure 1—figure supplement 2), suggesting that such cells are recruited as early as 48 hr
after the change in flow. However, transcripts from recruited or other contaminating cells repre-
sented a small portion of the total signal. This was assessed by the amount of eGFP (endothelial)
mRNA copies versus tdTomato (all other cells) in Cdh5(PAC)Cre-ERT2; mT/mG mice, in which eGFP
or tdTomato are driven from the same constitutive actin promoter in a cell-specific manner (Fig-
ure 1—figure supplement 3). By this measure, contaminating transcripts represented <1.5% of
RNA analyzed.
Murphy et al. eLife 2018;7:e29494. DOI: https://doi.org/10.7554/eLife.29494 2 of 21
Research article Cell Biology
Figure 1. Exposure of the arterial endothelium to low and disturbed flow induces a program of alternative splicing. RNA from the arterial endothelium
was isolated 48 hr after partial carotid ligation; from the low-flow side, the high-flow side, or sham-operated vessels. (A) Outline of splicing analysis.
Three pools of mRNA from each condition were isolated by polyA and sequenced. (B) Plot showing the consistency of changes in gene expression in
two independent biological comparisons of low-flow versus high-flow isolations. (C) Number of RNA splicing events of each category detected by
MISO analysis as significantly different in two independent biological comparisons. Events were drawn from annotated databases (Burge, Tian) or from
custom annotation of mapped splice junctions (novel). (D) Plot showing the changes in skipped-exon inclusion level (deltaPsi) between low-flow and
high-flow isolations. The plot also indicates changes in transcription, highlighting exons in genes with a change in FPKM of more than 2-fold up or
down. (E) Processes enriched in the genes with regulated skipped exons, relative to the entire set of genes expressed in the tissue with annotated
skipped exons which were not significantly regulated. Padj = Adjusted P-value, BF = Bayes Factor; FPKM = Fragments Per Kilobase of transcript per
Million mapped reads; CCDS = Consensus Coding DNA Sequence.
DOI: https://doi.org/10.7554/eLife.29494.002
The following source data and figure supplements are available for figure 1:
Source data 1. Contains DESeq2 output from the analysis of biological triplicates of low flow and biological triplicates of high flow, where each biologi-
cal triplicate contained 4–5 carotid flushes.
DOI: https://doi.org/10.7554/eLife.29494.008
Source data 2. Contains MISO from Tophat alignments of 80 bp reads, as described in the methods.
DOI: https://doi.org/10.7554/eLife.29494.009
Source data 3. Contains bowtie alignments to eGFP or tdTomato for the indicated samples as described in the methods.
DOI: https://doi.org/10.7554/eLife.29494.010
Figure supplement 1. Gene expression changes between low-flow and high-flow intima are mainly due to low flow.
DOI: https://doi.org/10.7554/eLife.29494.003
Figure supplement 2. Hematopoietic cell recruitment within 48 hr of low and disturbed flow.
DOI: https://doi.org/10.7554/eLife.29494.004
Figure 1 continued on next page
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Having established endothelial enriched RNA pools from the various flow conditions, we then
asked whether alternative splicing in intimal endothelial cells was regulated by flow. We assessed
levels of alternative exon inclusion, expressed as ‘percentage spliced in’ (Psi), in each condition and
their differences using the MISO Bayesian statistical framework (Katz et al., 2010). We examined
annotated events as well as novel events (see Materials and methods). Setting a threshold of signifi-
cance at Bayes factor five in two biologically independent comparisons of low flow to high flow, we
identified 768 regulated splicing events between known exons (skipped or mutually exclusive exons,
retained introns, or alternative 5’ or 3’ splice sites) and over a thousand regulated changes to the
last exon or 3’UTR (Figure 1C). As with the transcript level changes, the vast majority of the splicing
changes were induced by low flow, rather than high flow, in comparison with sham-operated vessels
(Figure 1—figure supplement 4). Approximately, 90% of the splicing changes observed in vivo
were recapitulated (at least 50% in the same direction) in purified endothelial cells in vitro, support-
ing the endothelial regulation of these splicing events (Figure 1—figure supplement 5). It is not
clear whether the 10% of events not similarly regulated in vitro reflect differences in the in vitro sys-
tem or transcript variants from the ~1.5% contaminating mRNA.
Because the mechanisms of regulation of skipped exons are best understood, and because we
are interested in alternative splicing events similar to the skipped exons in Fn, we focused on this
subclass of alternative splicing events (Murphy and Hynes, 2014). Changes in skipped exons were
consistent between completely independent biological sets, and not obviously correlated with
increased or decreased abundance in the transcriptional levels of these genes between conditions
(Figure 1D, each point indicates a regulated splicing event, colored points indicate events in genes
with altered transcript levels). The majority of the skipped exons were as strongly conserved evolu-
tionarily as constitutive exons in placental mammals, and much more so than introns (data not
shown). Genes with regulated skipped exons had annotated functions in several categories
(Figure 1E). Thus, altered flow results in changes in RNA splicing of exons coincident with, but inde-
pendent of, transcriptional changes.
Platelets are required for regulation of a subset of flow-regulated
skipped exons
We previously observed that monocyte recruitment was required for increased inclusion of Fn-EIIIA
and EIIIB exons after 48 hr of low flow (Murphy and Hynes, 2014). Platelets and granulocytes are
also recruited to arterial endothelium in regions of low and disturbed flow (Che`vre et al., 2014;
Huo et al., 2003; Massberg et al., 2002). We depleted each of these recruited cell types using
clodronate liposomes for macrophages (Murphy and Hynes, 2014), anti-GPIba for platelets and
anti-Gr1 for neutrophils (Labelle et al., 2014). Platelets were essential for the recruitment of both
macrophages and neutrophils in our system (Figure 2—figure supplement 1). Platelet depletion
resulted in suppression of Fn-EIIIA and –EIIIB relative to control treatments, and in widespread
changes in a large number of other flow-regulated skipped exons (Figure 2—figure supplement 2).
For the platelet-regulated skipped exons (about 1/3 of all flow-regulated skipped exons), platelet
depletion causes low-flow arteries to cluster with high-flow arteries in their splicing profile rather
than with IgG or untreated low-flow arteries (Figure 2A). Thus, platelets are necessary for the regu-
lation of many of the low-flow regulated skipped exons we observed.
In vivo experiments were unable to discriminate between the effects of platelets and macro-
phages on the splicing response of endothelium, since platelet depletion suppressed macrophage
recruitment. To address more directly the specific requirement for each blood cell type, we pre-
pared a murine aortic endothelial cell line for in vitro co-culture experiments (Figure 2—figure sup-
plement 3). We first examined EIIIA inclusion levels (Figure 2B1). Cultured cells in static conditions
Figure 1 continued
Figure supplement 3. Enrichment of endothelial RNA demonstrated by lineage markers in mT/mG mice.
DOI: https://doi.org/10.7554/eLife.29494.005
Figure supplement 4. Splicing changes are primarily induced by low flow rather than high flow.
DOI: https://doi.org/10.7554/eLife.29494.006
Figure supplement 5. Arterial cells cultured in vitro replicate splicing changes observed under low and disturbed flow in vivo.
DOI: https://doi.org/10.7554/eLife.29494.007
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had higher baseline levels of EIIIA than high-flow arteries in vivo (compare bars 2 and 3). Co-culture
with monocyte-derived macrophages, at similar stoichiometric ratios with the endothelial cells to
those observed in vivo in low-flow arteries, did not further increase EIIIA inclusion. However, both
platelets and plasma independently induced increased EIIIA inclusion, and exerted combinatorial
effects, resulting in inclusion levels approximately 6-fold higher than in vivo levels when all three
were added [EIIIA (from 15% to 80%) and EIIIB (from 11% to 60%)]. A broader examination of splic-
ing changes, by RNA-seq, revealed that half (40 of 80) of the splicing events regulated by platelets
Figure 2. Platelets and macrophages regulate a subset of flow-regulated skipped-exon events. (A) Effects of platelet depletion on splicing patterns in
vivo (see also 2–2). Clustered heat map showing the change in skipped-exon inclusion frequency relative to high-flow contralateral arteries in biological
replicates of untreated arteries (from data set created in Figure 1) or platelet-depleted (anti-GPIba) or IgG control-treated (IgG) arteries. The data
shown are for the platelet-dependent subset of all flow-regulated skipped exons (SE; 80/292). IgG and anti-GPIba (low flow) are relative to average IgG
(high flow). No antibody treatment in vitro and in vivo low flow are relative to average in vivo high flow. (B) Effects of platelet, macrophage and plasma
addition to endothelial cells in vitro. (B1) Bar graphs showing in vitro changes in EIIIA inclusion frequency and Cd68 macrophage marker expression
with the different treatments of conditionally immortalized aortic endothelial cells, relative to in vivo low-flow and high-flow samples. (B2) Plot showing
the in vitro regulation of platelet-regulated skipped-exon events (40/80), in isolated and conditionally immortalized aortic endothelial cells. (B3)
Clustered heat map, showing the change in skipped exon inclusion frequency in in vivo biological replicates of low-flow arteries with or without platelet
depletion (in vivo low-flow+ IgG control, +GPIba) or conditionally immortalized aortic endothelial cells with the addition of the indicated cells or 10%
plasma.
DOI: https://doi.org/10.7554/eLife.29494.011
The following source data and figure supplements are available for figure 2:
Source data 1. Contains MISO from STAR alignments of 100 bp reads, as described in the methods.
DOI: https://doi.org/10.7554/eLife.29494.015
Source data 2. Contains ratio of EIIIA or EIIIB to total FN in the indicated samples.
DOI: https://doi.org/10.7554/eLife.29494.016
Figure supplement 1. Hematopoietic cell depletion in aortic intima 48 hr after induction of low and disturbed flow.
DOI: https://doi.org/10.7554/eLife.29494.012
Figure supplement 2. In vivo depletions of individual hematopoietic cell populations and their effects on Fn-EIIIA and –EIIIB inclusion.
DOI: https://doi.org/10.7554/eLife.29494.013
Figure supplement 3. Isolation and conditional immortalization of aortic endothelial cells.
DOI: https://doi.org/10.7554/eLife.29494.014
Murphy et al. eLife 2018;7:e29494. DOI: https://doi.org/10.7554/eLife.29494 5 of 21
Research article Cell Biology
in vivo were similarly regulated by a combination of platelets, macrophages and plasma in vitro
(Figure 2B2). For this set of events, the addition of plasma, macrophages and platelets to cultured
endothelial cells induced a low-flow-like change in splicing but the individual components - platelets,
macrophages or plasma proteins - were unable to entirely recapitulate the potent effects of their
combination (Figure 2B3). Thus, platelets alone were insufficient to induce low-flow regulated
skipped exons, despite static in vitro conditions, and required both macrophages and plasma for
maximal effect.
Together our results suggest that recruitment of both platelets and macrophages to the arterial
endothelium is required for the flow-responsive splicing pattern in a large set of genes, including the
Fn-EIIIA and EIIIB exons.
Binding motif for the splicing factor Rbfox2 is enriched in regulated
vascular splicing events
We were particularly interested in the set of skipped exons induced in the endothelium in a platelet
and macrophage-dependent manner, along with Fn-EIIIA and –EIIIB, and asked whether there might
be a common upstream regulatory factor. Although analysis of transcriptional levels did not reveal
obvious candidate splicing factors (Figure 3—figure supplement 1), the identity of relevant splicing
regulators can in some cases be deduced by looking for enrichment of their RNA-binding motifs
adjacent to regulated exons, where they typically bind to exert their effects (Shapiro et al., 2011).
To take an unbiased approach to the identification of regulatory splicing factors by flanking
motifs, we developed an analysis pipeline using the ranking algorithm in GSEA and taking advantage
of the recent development of a comprehensive database of RNA-protein binding preferences
(CisBP-RNA) to provide the RNA-binding protein ‘finger-prints’ to be ranked (Ray et al., 2013). We
confirmed that this pipeline was able to correctly identify known regulatory splicing factors from raw
RNA-seq data from single-cell in vitro systems or complex in vivo tissues (Figure 3—figure supple-
ment 2).
Having confirmed our pipeline, we then applied it to assess the regulation of skipped exons in
the increasingly narrowly defined group regulated in vivo and in vitro by recruited platelets and mac-
rophages (Figure 3A and B). Enrichment was judged relative to background sets created from
known skipped exons expressed but not regulated in endothelial cells (see Materials and methods
for details). The Rbfox family, of which Rbfox2 is known to regulate EIIIB (Underwood et al., 2005),
stood out among this group, being enriched especially on the downstream side of exons with
decreased inclusion and, to a lesser extent, on both the upstream and downstream side of exons
with increased inclusion (Figure 3C–E).
Rbfox2 motifs in the flanking regions of the regulated events were conserved, consistent with the
conservation of the exons themselves (Figure 3—figure supplement 3). The Rbfox family contains
three members, Rbfox1-3, with conserved RNA-binding motifs. To determine which of these might
be most important in regulation of the EIIIA and EIIIB cohort of events, we examined their expres-
sion in vivo, and in in vitro purified endothelial cells. We found that only Rbfox2 was significantly
expressed in arterial endothelial cells (Figure 3F).
Thus, bioinformatics analysis suggests Rbfox2 as a particularly important regulator of the skipped
exon changes induced by platelet and macrophage recruitment to the arterial endothelium under
low flow conditions.
Endothelial-specific deletion of Rbfox2 partially reverts flow-responsive
skipping of vascular skipped exons induced by low flow in vivo
To test whether Rbfox2 is involved in the splicing response of the arterial endothelium to low flow,
we genetically removed Rbfox2 in mice using an endothelial-specific and inducible Cre (Cdh5(PAC)-
CreERT2) in combination with floxed Rbfox2 alleles (Gehman et al., 2012; So¨rensen et al., 2009).
This strategy resulted in efficient deletion of Rbfox2 without an increase in expression of the other
Rbfox family members, 1 and 3 (Figure 3F; EC-KO).
To allow us to assess both the low-flow-responsive splicing patterns and the chronic transcrip-
tional response of the flow-activated intima, we examined the effect of Rbfox2 deletion 7 days after
the reduction in flow. Consistent with our previous observations on Fn-EIIIA and –EIIIB, we found
that most splicing changes observed at 48 hr were also observed at 7 days (Murphy and Hynes,
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Figure 3. Enrichment of an Rbfox motif in the platelet/macrophage-regulated subset identified in vivo and in vitro. (A) Motif analysis pipeline, showing
the number of potentially regulated skipped-exon events, and those passing each filter. (B) Events were separated into those with increased or
decreased inclusion, and then the sequences of the upstream and downstream 200 bp flanking regions were isolated, resulting in four regions of
analysis. 6-mer motifs in each region were assessed for enrichment relative to exons expressed in six matched background sets of skipped exons not
regulated by flow. GSEA was used to identify splicing factor ‘fingerprints’ among these enriched motifs, using the motif-binding preference defined by
the CisBP-RNA database (Ray et al.). (C) Example of enrichment of Rbfox binding motif in GSEA analysis of 85-unique RNA-binding protein signatures
against flanking intron sequences of flow-regulated exons. Plot shows enrichment of Rbfox family motifs among the motifs most enriched above
background in the downstream flanking region of exons regulated in vivo and in vitro (set iii). (D) Enrichment of the Rbfox2 motif in each of the sets of
biologically defined regulated exons (i-iii) within the upstream and downstream flanking regions of exons with either increased or decreased inclusion.
(E) Plot showing the average z-score enrichment of the top 5 Rbfox in vitro defined motifs in the flanking regions of the in vivo regulated exon set (80
SE) and the in vitro regulated subset (40 SE), relative to the six matched background sets (N = 6 per bar). (F) Transcript levels of Rbfox family of proteins
in the carotid artery in vivo and in isolated aortic endothelial cells in vitro, with or without the deletion of Rbfox2 by Cdh5(PAC)-CreER (EC-KO).
FPKM = Fragments Per Kilobase of transcript per Million mapped reads. FDR; false-discovery rate; n.f.; not found. p<0.0001 (****), p<0.01 (**).
DOI: https://doi.org/10.7554/eLife.29494.017
The following source data and figure supplements are available for figure 3:
Source data 1. Contains the pared down list of flow-regulated events and their annotations (e.g. platelet regulated).
DOI: https://doi.org/10.7554/eLife.29494.021
Source data 2. Contains the list of intervals used for motif enrichment around the indicated regulated exons for the indicated sets (e.g. increased inclu-
sion in flow regulated set).
DOI: https://doi.org/10.7554/eLife.29494.022
Source data 3. Contains a list of expressions across samples for all known RNA binding proteins.
DOI: https://doi.org/10.7554/eLife.29494.023
Source data 4. Contains the list of all motifs, their enrichment adjacent to regulated exons, their conservation score, and the z-score enrichment of the
motif from the CisBP-RNA database.
DOI: https://doi.org/10.7554/eLife.29494.024
Figure supplement 1. No obvious candidate splice factors from differential expression under altered flow conditions.
DOI: https://doi.org/10.7554/eLife.29494.018
Figure supplement 2. Positive control sets to confirm the motif-based identification of regulated events in vitro and in vivo by their CisBP-RNA
fingerprint in GSEA.
DOI: https://doi.org/10.7554/eLife.29494.019
Figure 3 continued on next page
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2014). We found that Rbfox2 was important in the flow-responsive splicing change of many of the
previously defined skipped exons, including Fn-EIIIB and –EIIIA to a lesser extent (Figure 4A, and
Figure 3 continued
Figure supplement 3. Conservation of Rbfox2 motifs enriched near flow-regulated skipped exons.
DOI: https://doi.org/10.7554/eLife.29494.020
Figure 4. Endothelial Rbfox2 deletion affects many of the flow-regulated splicing events. (A) Showing the percentage of each group of skipped exons
regulated by endothelial deletion of Rbfox2 (BF >5) in any comparison and regulated similarly in both comparisons of Rbfox2 wt low-flow vs. Rbfox2
EC-KO low-flow – either consistent with the flow-induced change in splicing (red, ‘same’) or against the direction of the flow-induced change in splicing
(blue, ‘reverted’). (B) Heat map showing the clustering of flow-regulated splicing events reverted by Rbfox2 deletion (67 of the 273 events consistently
regulated between 48 hr and 7 days). 1 = C57 wild-type mice, 48 hr data set; 2 = C57 wild-type mice, IgG control 48 hr data set; 3 = Rbfox2 wt control
(i.e. no Cre), 7 days data set; Rb EC-KO = Rbfox2 EC-KO 7 days data set. (C) Effect of endothelial Rbfox2 deletion on flow-mediated regulation of
inclusion of Fbln2 alternative exons. (D) Plot shows the change in splicing of skipped exons (SE) following Rbfox2 deletion from carotid artery intima in
vivo (under low flow) or in isolated primary aortic endothelial cells in vitro. SE from the Rbfox2 regulated set of events, in genes expressed >FPKM 1 in
in vitro and in vivo sets. SE also regulated by a change in flow are highlighted.
DOI: https://doi.org/10.7554/eLife.29494.025
The following source data and figure supplements are available for figure 4:
Source data 1. Contains paired list of flow-regulated skipped exon events.
DOI: https://doi.org/10.7554/eLife.29494.028
Figure supplement 1. Rbfox2 deletion does not cause a reduction in markers of recruited platelets or macrophages.
DOI: https://doi.org/10.7554/eLife.29494.026
Figure supplement 2. Rbfox2 localization under serum stimulation in mouse aortic endothelial cells.
DOI: https://doi.org/10.7554/eLife.29494.027
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Figure 4—source data 1). Altogether, Rbfox2 deletion suppressed flow-induced splicing changes
of ~25% the skipped exons (Figure 4A, blue bars, right hand panel and 4B). This set of genes enco-
des extracellular matrix proteins (e.g. Fn1, Fbln2, Mfge8) and immune-regulatory proteins (e.g.
Ikbkg, Gpr116, Ceacam1). Analysis of inclusion of specific exons is shown in Figure 4C demonstrat-
ing the loss of flow-responsive exons of Fbln2 on endothelial deletion of Rbfox2.
Since suppression of flow-responsive splicing was also impaired by depletion of platelets and
macrophages, we asked whether recruitment of these cells was affected. However, we observed sim-
ilar levels of macrophage markers (Cd68, F4/80) in the low-flow intimal flushes in the presence and
absence of endothelial Rbfox2 (Figure 4—figure supplement 1), suggesting that recruitment of
macrophages, and by extension the platelets that we had previously found to be required for macro-
phage recruitment, were not detectably affected by deletion of Rbfox2.
Consistent with a direct effect of Rbfox2 depletion on endothelial cells, we found a good correla-
tion between the changes in splicing observed in vivo upon Rbfox2 deletion and those observed in
vitro with Rbfox2 deletion in primary isolated aortic endothelial cells (Figure 4D). Notably, changes
in splicing in vitro, in response to serum, did not correspond with an obvious alteration in the locali-
zation or abundance of Rbfox2 in the nucleus at the protein level (Figure 4—figure supplement 2).
Thus, Rbfox2 deletion in the endothelium prior to the induction of low flow suppresses a large
portion of flow-responsive alternative splicing in endothelial cells, downstream of platelet and mac-
rophage recruitment.
Endothelial deletion of Rbfox2 alters the intimal response to low flow
We predicted that changes in the splicing response of the arterial intima caused by Rbfox2 deletion
would affect the response to low flow. To test this, we examined gene expression at the whole tran-
script level 7 days after the induction of low flow in Rbfox2 EC-KO mice and littermate controls, and
in the isolated endothelial cells. We found that endothelial deletion of Rbfox2 significantly affected
Figure 5. Endothelial Rbfox2 deletion suppresses low-flow transcript response in the arterial intima. (A) Clustered heat map of the genes with adjusted
p-values<0.05 shows the change in expression relative to contralateral controls at 7 days after the change in flow in the indicated genotypes (N = 641).
(B) Enriched terms among the genes regulated by Rbfox2 deletion. (C) Volcano plot showing DESeq2 calculated p-values and log2 fold changes in
genes expressed in the arterial intima at 7 days of arteries exposed to low and disturbed flow, with or without deletion of Rbfox2. Genes selected for
qPCR in single arteries are shown. (D) Results of individual carotid artery qPCR for the genes indicated. Log2 fold-changes are relative to control, p
values are from Mann-Whitney test (N = 14 control and N = 18 Rbfox2 EC-KO).
DOI: https://doi.org/10.7554/eLife.29494.029
The following source data and figure supplement are available for figure 5:
Source data 1. Contains qPCR deltaCT between gene and housekeeping gene in the indicated samples, and the normalization to controls used to
determine fold-change.
DOI: https://doi.org/10.7554/eLife.29494.031
Figure supplement 1. Rbfox2-dependent transcriptional response found in vivo is specific to the low-flow arterial intima.
DOI: https://doi.org/10.7554/eLife.29494.030
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641 genes in the carotid intima under low flow (DESeq2 p-adj <0.05) (Figure 5A). Of these 641
genes, 507 are part of the 4766 gene low-flow signature previously described (Figure 1). Clustering
of expression changes in the Rbfox2-regulated subset of genes, relative to the contralateral artery of
control mice, shows that deletion of Rbfox2 causes the low-flow arterial intima to resemble more
closely the high-flow arterial intima (Figure 5A). Processes of cell proliferation and of antigen pre-
sentation were enriched among the differentially regulated genes (Figure 5B). RNA-seq was per-
formed on pooled arteries, and quantitative PCR analysis of selected regulated genes in individual
carotid arteries confirmed expression changes in individual animals (Figure 5C and D). These results
indicate that Rbfox2 is essential for a portion of the endothelial response to low flow,
regulating ~10% of the transcriptional response to low flow.
In contrast with our observation of correlations between splicing patterns in vivo and in vitro,
most transcriptional changes induced in the low-flow arterial intima were specific to the in vivo envi-
ronment and were not observed in a comparison of isolated aortic endothelial cells or in the contra-
lateral artery (Figure 5—figure supplement 1). In other systems, cytoplasmic Rbfox has been shown
to have an important role in the regulation of transcript stability through the 3’UTR
(Damianov et al., 2016; Lee et al., 2016). However, transcript levels regulated by Rbfox2 were not
any more associated with characterized 3’ UTR binding by iClip-Seq (Lee et al., 2016) than those
not regulated by Rbfox2 (iClip-Seq binding sites in 54/638 of the Rbfox2-regulated transcripts versus
1166/17130 of the transcripts not regulated by Rbfox2). Together, these data suggest that the con-
sequences of endothelial Rbfox2 deletion on transcriptional changes involved cross-talk among cell
types (e.g. effects of altered endothelial splicing on recruited immune cells) or other microenviron-
mental effects in the flow-activated intima in vivo not replicated in vitro.
Thus, Rbfox2 deletion affects skipped exon splicing patterns in endothelial cells, and results in
the reversion of a large set of low-flow-induced gene expression changes in the arterial intima.
Discussion
Here, we report that recruitment of circulating hematopoietic cells to the arterial endothelium under
low flow initiates an alternative splicing response regulated in part by Rbfox2. Profiling global tran-
scriptional changes induced in the arterial endothelium by experimentally induced low flow, we
show that hundreds of transcripts are regulated by alternative splicing. Focusing on skipped exons
in particular, we find that one third of those affected by altered flow are dependent on recruited
hematopoietic cells in vivo, particularly platelets. Rbfox-binding motifs are significantly enriched
adjacent to these exons. Mechanistically, deletion of endothelial Rbfox2 reverts many of the flow-
induced changes in splicing and suppresses ~10% of the flow-induced changes in transcription. Pro-
cesses related to genes with changes in either splicing or transcription included cytoskeleton, cell
adhesion, proliferation and antigen presentation suggesting that Rbfox2 may regulate these biologi-
cal processes in the aortic intima downstream of hematopoietic cell recruitment.
Broad regulation of alternative splicing by flow in the arterial
endothelium
Low flow exerts potent effects on the vasculature through the endothelium, which are achieved by
effects on endothelial transcription, epigenetic regulation, and post-translational protein modifica-
tions and reorganization (Gimbrone and GarciaGarcı´a-CardenaCarden˜a, 2016). Our work reveals
widespread changes in alternative splicing affecting a number of genes known to be critical in the
pathways already implicated in the response to altered flow, inflammation, remodeling and flow-
driven vascular disease. Examples include Pecam1, a component of the shear-sensing mechanism in
the endothelium (Tzima et al., 2005), Yap1, a regulator of mechanical activation (Dupont et al.,
2011) and Ikbkg (Nemo), a regulator of NFkappa-B signaling (Li et al., 1999). In previous work, dif-
ferential splicing of Vcam1 was detected in IL-1-stimulated HUVECs (Cybulsky et al., 1991) and of
Fn in TGFb-induced liver sinusoidal endothelium (Chang et al., 2004). Exon arrays have also shown
differential exon usage in HUVECs in response to hypoxia (Hang et al., 2009; Weigand et al.,
2012). However, this hypoxic response appears to be very different from the responses we have
observed, and less then 2% of the genes in which we detected alternative splicing overlap with those
found in the hypoxic signature of HUVECs. It is possible that this is due to methods used (exon
arrays versus our sequencing approach), cell type (HUVECs versus murine aortic endothelial cells), or
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pathway-specific responses. The latter is likely, since we observed no consistent regulation of hyp-
oxia-induced genes (e.g. Vegfa) in the flow-responsive signature. Alternative splicing responses are
distinct, similar to transcriptional responses (Graveley et al., 2011). Indeed, even within the alterna-
tive-splicing response to altered flow, we are able to detect a distinct response dependent on the
recruitment of circulating hematopoietic cells.
Biological consequences of alternative splicing programs induced by
low flow
We do not yet know the function of most of the splicing changes we have observed. Unlike mice
deficient in both EIIIA and EIIIB, which exhibit an increased risk of arterial rupture under low flow,
Rbfox2 EC-KO mice do not. This may be due to the lesser effect of Rbfox2 deletion on EIIIA than
EIIIB in the Rbfox2 mutant mice (EIIIA inclusion was 50% in Rbfox2 EC-KO low-flow artery, versus
60% in WT low-flow artery, compared with 20% in high flow artery; while EIIIB inclusion was absent
in all Rbfox2 EC-KO conditions). In previous work, we found that EIIIA-/- replicated much of the
effect of the EIIIAB-/- mice; loss of EIIIB may have other consequences than loss of EIIIA
(Murphy and Hynes, 2014).
Nevertheless, we have reason to believe that these splicing changes are biologically important.
First, the alternatively spliced exons comprising this response, including Fn-EIIIA and -EIIIB, are
highly conserved among all placental mammals. In fact ~80% of the flow-regulated skipped exons
are as well conserved as consensus coding exons (CCDS). Conservation of sequence is not necessar-
ily the same as conservation of regulation (Kalsotra et al., 2008; Li et al., 2015; Merkin et al.,
2012; Pai et al., 2016; Yeo et al., 2005). Nevertheless, the conservation of regulatory regions, spe-
cifically the Rbfox2 motif, surrounding the skipped exons support conserved regulation as well. Sec-
ond, deletion of a regulator of this splicing program, Rbfox2, affects the transcriptional response of
the intima to low flow. Notably, both genes with Rbfox2-regulated transcript levels, and those with
Rbfox2-regulated skipped exons were enriched in functions related to cytoskeletal remodeling, cell
adhesion, and antigen presentation (Figure 1 and Figure 5). The particular genes regulated in each
way (transcript abundance and splicing) did not directly overlap, suggesting that similar biological
processes may be targeted through both transcriptional and post-transcriptional mechanisms in
Rbfox2 EC-KO mice. Given the known activation of TLR4 signaling by EIIIA (Okamura et al., 2001),
a key player in adaptive immunity, the potential impact on antigen presentation and the adaptive
response warrants further research.
Regulation of alternative splicing in the aortic endothelium by platelets
and macrophages
Much of the work to date on flow-induced changes in gene expression in the arterial endothelium
has focused on the initial response to flow, which increases the transcriptional expression of adhe-
sion receptors and chemokines involved in the recruitment of circulating immune cells (Conway and
Schwartz, 2013; Ley et al., 2007). This has been a consequence of efforts to identify the first events
leading to endothelial dysfunction under low flow. However, once circulating hematopoietic cells are
recruited, they initiate ongoing interactions in the arterial wall likely to affect the ultimate outcome
of flow-induced arterial injury (Pober and Sessa, 2007). Flow-driven vascular inflammation occurs as
a chronic process, involving components of the innate and adaptive immune systems (Galkina and
Ley, 2009; Pober and Sessa, 2007). Here, we show that recruitment of platelets and monocytes/
macrophages in particular potently regulate alternative splicing in the arterial endothelium. Within
this response, we observed alterations in a number of pathways that may impact ongoing interac-
tions at the arterial wall. Thus, subsequent to the well-studied events leading to recruitment of
immune cells, their interactions with the arterial endothelium appear to be affecting pathways that
may help to shape the chronic inflammatory response.
Endothelial functions of Rbfox2
Rbfox2 is one of three Rbfox family members (Rbfox-1,-2 and -3). The Rbfox family of splice factors
and the motif recognized by their RNA-binding domain are conserved throughout the vertebrates
examined and also in C. elegans (Underwood et al., 2005). The motif which the Rbfox family recog-
nizes was first identified adjacent to Fn-EIIIB (Huh and Hynes, 1993, 1994), which we find to be
Murphy et al. eLife 2018;7:e29494. DOI: https://doi.org/10.7554/eLife.29494 11 of 21
Research article Cell Biology
dependent on Rbfox2 in our system, consistent with previous work in other systems (Jangi et al.,
2014). The Rbfox family has been shown to have important functions in heart (Gao et al., 2016),
muscle (Singh et al., 2014), and brain development (Gehman et al., 2012) and EMT in cancer
(Shapiro et al., 2011). De novo mutations in Rbfox2 have also been identified in congenital heart
disease (Homsy et al., 2015), and alterations in Rbfox2 activity may be an early event in diabetes-
induced heart pathology (Nutter et al., 2016). In both heart and brain, Rbfox2 has been shown to
have a requirement in maintenance of tissue functions (Gao et al., 2016; Gehman et al., 2012). In
contrast to the other tissues mentioned, Rbfox2 is the only member of the Rbfox family expressed in
the arterial endothelium.
How Rbfox2 modulates splicing activity in this system remains unknown. We observe modest
changes in expression of Rbfox2 (<20% increase in RNA in arterial endothelium exposed to low flow
in vivo). Similar modest changes were observed in the in vitro system, in which we induced splicing
changes with co-culture of platelets, monocytes and plasma. How else might Rbfox2 splicing activity
be regulated? One possibility we examined is that upstream cues from platelet and monocyte
recruitment alter sub-cellular localization of the Rbfox2 protein. However, we observed no obvious
loss in nuclear Rbfox2 localization in vitro under conditions in which splicing changes are induced
(Figure 4—figure supplement 2), suggesting that activity may be regulated in some other way.
These data, together with the observation that deletion of Rbfox2 results in splicing alterations more
widespread than the low-flow response alone (Figure 4D), suggest that the specificity of the endo-
thelial splicing response is driven by other flow-responsive factors acting in an Rbfox2-dependent
manner.
We have focused on the splicing functions of Rbfox2. However, in addition to affecting splicing
patterns, Rbfox2 has also been reported to regulate gene expression patterns by other mechanisms.
Splicing of Rbfox2 targets has been shown to regulate transcript stability (Jangi et al., 2014).
Through recruitment of polycomb complexes to DNA, Rbfox2 may affect transcript expression
(Wei et al., 2016). Rbfox2 may also stabilize transcripts directly by binding to the 3’UTR
(Damianov et al., 2016; Lee et al., 2016), suppressing the formation of isoforms destined for non-
sense-mediated decay (Jangi et al., 2014). However, as we observed no enrichment of known
Rbfox-binding sites in the 3’UTR of regulated transcripts and no regulation of transcript levels in
vitro which were regulated in vivo, we believe that many of the transcript level changes mediated by
deletion of Rbfox2 are due to downstream or non-cell autonomous effects. Future work, examining
the functional effects of individual splicing events identified will be important in teasing apart splic-
ing-dependent and -independent effects.
In conclusion, we report that hundreds of splicing changes are regulated in endothelial cells
exposed to an acute reduction in blood flow, many of which were dependent on recruitment of pla-
telets and monocytes to the arterial wall and impact key pathways in endothelial cell biology. Rbfox2
emerged as an important regulator in this system, and its depletion resulted in a partial suppression
of transcriptional responses characteristic of low-flow-induced endothelial activation. Thus, Fn is only
one of many genes affected by splicing changes in the activated vascular endothelium. Alterations in
Fn splicing contribute to a variety of vascular diseases with an inflammatory component; stroke
(Dhanesha et al., 2015), atherosclerosis (Tan et al., 2004), myocardial infarction (Arslan et al.,
2011), organ transplant and other fibroses (Bhattacharyya et al., 2014; Booth et al., 2012). There-
fore, further investigation of the other alternative splicing events we have identified here may
uncover novel regulatory mechanisms in chronic inflammatory disease.
Materials and methods
Key resources table
Reagent type (species) or resource Designation Source or reference Identifiers
antibody anti-GP1ba Emfret RRID:AB_2721041
antibody anti-Gr1 Biolegend RRID:AB_467731
antibody anti-Rbfox2 Bethyl Labs RRID:AB_609476
commercial assay or kit SMARTer Universal Low Input RNA Kit Clontech
Continued on next page
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Continued
Reagent type (species) or resource Designation Source or reference Identifiers
commercial assay or kit RNAeasy microcolumns Qiagen
software, algorithm RSEM v.1.2.15 GitHub RRID:SCR_013027
software, algorithm MISO v.0.4.9 GitHub RRID:SCR_003124
software, algorithm STAR 2.5.1b GitHub RRID:SCR_015899
software, algorithm Tophat 2.0.6 GitHub RRID:SCR_013035
software, algorithm Bowtie2 v. 2.0.5 GitHub RRID:SCR_005476
software, algorithm GSEA http://www.gsea-msigdb.org/gsea/index.jsp RRID:SCR_003199
strain, strain background (M. musculus) Rbfox2lox/lox Jackson Lab RRID:IMSR_JAX:014090
strain, strain background (M. musculus) Rosa26-mTmG Jackson Lab RRID:IMSR_JAX:007676
strain, strain background (M. musculus) Cdh5(PAC)-CreERT2 Jackson Lab RRID:IMSR_TAC:13073
strain, strain background (M. musculus) C57BL/6J Jackson Lab RRID:IMSR_JAX:000664
Flow alterations
Partial carotid ligations were performed as previously described (Ni et al., 2010), with minor modifi-
cations (Murphy and Hynes, 2014). Briefly, the distal branches of the left carotid artery were identi-
fied in mice anesthetized with isoflurane. The left external carotid, internal carotid, and occipital
artery were ligated with 9–0 Ethilon suture, leaving only the superior thyroid artery intact. Sham
operations consisted of the same carotid dissection and encircling with suture, except that the ves-
sels were not tied off. High-resolution ultrasound, using the VisualSonics Vevo 770, was performed
at the experimental endpoint (2–7 days after partial carotid ligation) to confirm vessel patency.
RNA-isolation and sequencing
Isolation of intimal RNA was performed as previously described from the carotid intima
(Murphy and Hynes, 2014; Ni et al., 2010). Briefly, vessels were isolated and imaged from eutha-
nized mice, flushed with PBS solution and then 150 mL Trizol. RNA from cultured aortic endothelial
cells was isolated after one week in culture by sorting 1–2K endothelial cells (by CD31+ and Icam2+)
from BD Aria directly into cold Trizol solution. RNA from all samples was isolated with Qiagen
RNAeasy microcolumns. Pools of RNA were created and then DNAse-treated in solution, before
concentrating on RNAeasy columns with elution in minimal volume. RNA quality was assessed by
Agilent Bioanalyzer or Advanced Analytical, library preparation was performed using the Clontech
SMARTer Universal Low Input RNA Kit, and samples were sequenced on Illumina HiSeq 2000 or
NextSeq 500 using 80 bp paired-end (PE) reads (triplicates of low-flow, sham and high-flow), 100 bp
PE reads (re-sequencing of triplicates of low-flow, sham and high-flow, and cultured aortic endothe-
lial cells) or 150 bp PE reads (hematopoeitic cell depletions with controls and endothelial Rbfox2
deletion with controls in vivo and in vitro). Base calls were performed using the Offline Base Caller
(Illumina) v. 1.9.4 and reads mapping to different genomic features were tallied and read densities
were compared for each sample.
Read-mapping and transcript analysis
For experiments with alteration of flow (triplicates of low-flow, sham and high-flow), reads were
trimmed to 80 bp and mapped with Tophat 2.0.6 and Bowtie2 v. 2.0.5, allowing the detection of
novel junctions, with options -p 8 –read-edit-dist 4 –min-intron-length 10 –read-mismatches 4 –max-
intron-length 1000000 –read-realign-edit-dist 0 –mate-std-dev 30 –segment-length 20 –library-type
fr-firststrand -r 50, guided (-G) by an mm9-based refseq gtf file [https://www.ncbi.nlm.nih.gov/
pubmed/23618408].
For experiments with alteration of flow with or without depletion of hematopoeitic cells or dele-
tion of Rbfox2, 150 bp reads were mapped with STAR 2.5.1b and options –runThreadN 8 –runMode
alignReads –outFilterType BySJout –outFilterMultimapNmax 20 –alignSJoverhangMin 8 –alignSJD-
BoverhangMin 1 –outFilterMismatchNmax 999 –alignIntronMin 10 –alignIntronMax 1000000 –
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alignMatesGapMax 1000000 –outSAMtype BAM SortedByCoordinate –quantMode Transcriptome-
SAM [https://www.ncbi.nlm.nih.gov/pubmed/23104886].
RSEM v.1.2.15 (options –paired-end –calc-ci -bam -p 8 ) was used to calculate transcript levels
[https://www.ncbi.nlm.nih.gov/pubmed/21816040], and DESeq2 v1.10.1 in the R statistical environ-
ment v3.2.3 was used to calculate differential transcript levels using the DEseq() integrated com-
mand with default parameters, which estimates library sizes and dispersions and fits a negative
binomial generalized linear model for fold-changes and Wald statistics estimation using a 2-condi-
tion design. [https://www.ncbi.nlm.nih.gov/pubmed/25516281].
For eGFP and Tomato analysis, a custom index containing eGFP and tdTomato sequences was
created, and bowtie was used to align reads to this index using options –best –strata -m 1 –q. The
number of reads mapping to eGFP and to tdTomato were counted, and % tdTomato reads deter-
mined [tdTomato reads / (tdTomato+ eGFP reads) *100%].
Splicing analysis
Positive control data sets for regulation of splicing by Rbfox2 in vitro or by Mbnl in vivo were taken
from published data, and run through our own informatics pipeline (Jangi et al., 2014; Wang et al.,
2015).
MISO v.0.4.9 was used to determine differential splicing regulation. The SE, A3SS, A5SS, RI and
MXE event index was derived from the MISO splicing events database (mm9 version 2). Briefly, this
set of events was derived by considering all transcripts annotated in Ensembl genes, knownGenes
(UCSC) and RefSeq genes (as of June 2013). The ALE and TandemUTR events index was derived
from the MISO database compiled from published data, made available on the MISO website
(Hoque et al., 2013). Additional novel SE, A3SS, A5SS and MXE events were detected using a
method developed by Paul Boutz. Identification and classification of novel alternative splicing events
was performed as described in Boutz et al. (2015). Briefly, mapped splice junctions were filtered for
minimal transcript level and classified as SE, A3SS, A5SS, or MXE without reference to annotated
exonic loci. This set of novel events was then used to generate a novel index, which was passed
through the same MISO pipeline as all other indices.
Selection of subgroups of regulated exons
Flow-regulated: BF >5 in two completely independent biological comparisons of low flow versus
high flow, where the difference between high flow and low flow is >2 x the difference between repli-
cate high-flow conditions.
Flow-regulated and endothelial
Of the events above, at least 50% of the difference between low-flow in vivo and high flow in vivo
must be recapitulated in differences between FACs-purified mouse arterial cells in culture and high-
flow cells in vivo.
Flow-regulated and endothelial and platelet-regulated
Of the events above, if platelet depletion reverted flow-induced splicing changes by >50% in two
completely independent biological comparisons.
Flow-regulated and endothelial and platelet-regulated and in vitro
regulated
Of the events above, if the change in splicing induced in isolated aortic endothelial cells by the addi-
tion of platelets, macrophages and plasma was >50% of the flow-regulated change in splicing.
Rbfox2-regulated
If change in inclusion with Rbfox2 deletion was BF >5 in any of three comparisons, in vivo low-flow
Rbfox2 control vs. Rbfox2 EC-KO artery at 7 days, in vivo high-flow Rbfox2 control vs. Rbfox2 EC-
KO artery at 7 days, or in vitro Rbfox2 control vs. Rbfox2-deleted aortic endothelial cells, and consis-
tently changed in the same direction in all in vivo comparisons under low flow between Rbfox2 con-
trol and Rbfox2 EC-KO arteries. In this set, Rbfox2 control arteries have floxed alleles but no Cre
activity.
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Identification of enriched splice factor motifs adjacent to regulated
skipped exons
To perform motif enrichment analysis, we compared endothelial alternative skipped exons regulated
by blood cells in vivo and in vitro (the foreground) with skipped exons expressed by endothelial
cells, but not consistently regulated under the same conditions (the background). In general, the
foreground events were more often poised at an intermediate Psi level (neither complete inclusion
or exclusion). They also tended to be expressed at a higher level than background events. Thus, we
created background sets in which we normalized each of these parameters independently (data not
shown). We looked for motifs enriched either upstream (3’splice site, or 3’SS) or downstream (5’
splice site, or 5’SS) of the regulated exons. Since the direction of change in exon inclusion, increased
dPsi or decreased dPsi, has been correlated with the location of splice factor binding, we further
separated the foreground into exons with increased (+dPsi) or decreased (-dPsi) inclusion. Intronic
sequences adjacent to the 3’SS and the 5’SS of skipped exons with increased or decreased inclusion
were isolated from mm9 sequence data using Bedtools 2.16.1 (getfasta –s), and enrichment was cal-
culated based on enrichment of 6-mer or 7-mer motifs in the foreground versus the background
sets, split across 10 GC-normalized bins, iterated multiple times.
From the lists of enriched motifs we obtained, we aimed to identify the likely RNA-binding pro-
teins. To do this in an unbiased manner, we used the CisBP-RNA data set, which includes 154 unique
motifs and 373 total murine RNA-binding proteins (Ray et al., 2013). We modified the ranking algo-
rithm GSEA, typically used to identify transcriptional signatures, to identify RNA-binding protein sig-
natures. A Kolmogorov-Smirnov statistic embedded in GSEA was used to identify which of these
RNA-binding-protein motif sets was most abundant at the leading edge of the ranked enrichment
set (Subramanian et al., 2005).
Depletion of innate immune cells
For platelet depletion experiments, mice were injected intraperitoneally with a single dose of plate-
let-depleting antibody (anti-GP1ba; 50 mg per mouse; R300; Emfret; RRID:AB_2721041) or IgG con-
trol at the time of partial carotid ligation. To deplete Ly6G+ cells, anti-Gr1 (RB6-8C5; BioLegend;
RRID:AB_467731) or IgG controls were administered by intraperitoneal injection (25 mg per mouse)
24 hr prior to partial carotid ligation. To deplete macrophages, mice were injected by tail vein with
150 mL clodronate liposomes or PBS liposome controls at the time of partial carotid ligation. Clodro-
nate liposomes or PBS liposomes were purchased from ClodronateLiposomes.com (Kruisweg 59,
2011 LB Haarlem, The Netherlands).
Mice
Male C57BL/6J mice from Jackson Laboratories were used at 6–7 weeks of age for experiments on
the regulation of transcription and splicing in the carotid intima in wild-type mice, or in wild-type
mice with the depletion of various hematopoietic cells.
For the endothelial deletion of Rbfox2, Cdh5(PAC)-CreERT2, Rosa26-mTmG and Rbfox2lox/lox
mice have been previously described (Gehman et al., 2012; Muzumdar et al., 2007; Wang et al.,
2010) RRID:IMSR_JAX:014090, RRID:IMSR_JAX:007676, RRID:IMSR_TAC:13073. They were inter-
crossed to create the Rbfox2 EC-KO mice (Cdh5(PAC)-CreERT2; Rosa26-mTmG; Rbfox2lox/lox) and
littermate controls (Rosa26-mTmG and Rbfox2lox/lox) used here. Mice used were between 2 and 7
months of age in paired groups of males and females.
All mice were housed and handled in accordance with protocols approved by the Massachusetts
Institute of Technology Division of Comparative Medicine.
Aortic endothelial cell isolation
Mouse aortic endothelial cells were isolated following previously described methods
(Kobayashi et al., 2005), with modifications. Briefly, mice were perfused via the left ventricle with
PBS, the aorta was isolated and filled with 2% collagenase II (Worthington) in serum-free DMEM,
and then closed at the ends with 7–0 suture. The vessel was digested for 30–45 min in 10% FBS at
37C, and endothelial cells were flushed out into EC culture medium, and onto a collagen I-coated
plate. EC culture medium consisted of DMEM with 10% FBS and 10 mg/mL endothelial growth sup-
plement (ECGS, Biomedical Technologies) with primocin (InvivoGen). Typical isolations of ~1000 cells
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expanded to ~10,000–50,000 cells. Cells were then FACs-sorted (BD Aria) on endothelial markers,
eGFP for Cdh5(PAC)-CreERT2; Rosa26-mTmG on Pecam+ and Icam2+ for Cdh5(PAC)-CreERT2;
Rosa26-mTmG; Rbfox2lox/lox mice and littermate controls.
Aortic endothelial cell immortalization
After purification by FACs, endothelial cells were immortalized by lentiviral TetOn-Sv40T. The con-
struct was developed from a version of pTRIPZ (Clontech) with removal of the puro-selection cas-
sette. SV40 T antigen was inserted into the tet-regulated region of the lentivirus from pBabe-SV40T
(Zhao et al., 2003). After infection, cells were expanded in EC media with 2 mg/mL Doxycycline
(Dox).
Aortic endothelial cell co-culture
Cells derived from Cdh5(PAC)-CreERT2; Rosa26-mTmG, tamoxifen-treated in vivo, and then isolated
by FACs purification on eGFP, expanded and immortalized by TetOn-SV40T were trypsinized and
split in DMEM into new dishes, without Dox to turn off SV40T. After culture for 24 hr in DMEM, com-
binations of platelets, bone-marrow-derived monocytes, and/or 10% plasma were added for 48 hr.
Cells in plate were then imaged and lysed with Trizol for RNA extraction.
Platelets were isolated from the platelet-rich plasma (PRP) of C57BL/6J mouse blood by collec-
tion in ACD buffer. They were spun down at 500xG for 7 min with isolation of the upper PRP, from
which a platelet pellet was isolated after being spun down at 2800xG for 5 min and resuspended in
PIPES buffer. ~20 million platelets (in 6 mL PIPES) were added to each confluent well of endothelial
cells in the 24-well plate. Plasma was taken from C57BL/6J mouse blood collected in EDTA and
spun down at 2000xG for 15 min at 4˚C. 10% plasma was added to DMEM in 24-well plates. Bone-
marrow-derived monocytes were isolated from the femurs of C57BL/6J mice, flushed with 10% FBS
DMEM (+2 mM EDTA) into collection tube with 10 mL syringe and 25Ga needle, and then purified
using an EasySep Mouse Monocyte Isolation Kit (by negative selection, depleting Cd3+, Cd45R+,
Cd117+, Ly6G+, Nk1.1+, Siglec F+ cells). ~10K monocytes were added to each well of the 24-well
plate.
Aortic endothelial cell immunofluorescence
Cells (TetOn-Sv40, eGFP+ from Cdh5(PAC)CreERT2; mT/mG mice were cultured on poly-L-lysine
treated coverslips and treated or not with 10% serum (FBS) for 48 hr. Coverslips and cells were
washed with phosphate buffered saline (PBS) and fixed with ice cold methanol. Rbfox2 protein was
stained by anti-Rbfox2 (Bethyl Labs A300-864A, 1:1000; RRID:AB_609476), with goat anti-rabbit
Alexa594 secondary. Block was 10% normal goat serum in PBS with 0.1% tritonX-100.
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